Sanara Ventures

Sanara Ventures functions as a specialized seed-stage investment platform, actively backing early-stage companies within the health technology sector. The firm strategically invests across digital health, bio-convergence, and medical devices, supplying essential capital and guidance. It aims to accelerate novel healthcare innovations to market.

Established in 2015, Sanara Ventures originated as a strategic initiative between industry leaders Philips and Teva Pharmaceuticals. This partnership stemmed from a shared understanding of the critical need to cultivate and scale emerging healthcare technologies. Its inception provided a focused framework to foster innovation within Israel's health-tech ecosystem.

Sanara Ventures primarily supports entrepreneurial teams developing disruptive solutions for global healthcare. Its overarching vision is to build a robust portfolio of successful health-tech enterprises that significantly impact patient care. The firm strives to drive advancements improving overall health outcomes globally.